A method for inhibiting restenosis associated with mechanical injury of a
blood vessel. An adenoviral vector encoding a suicide gene such as
thymidine kinase is directly administered to the injured vessel followed
by treatment with a nucleotide analog. The analog is phosphorylated and
converted to a cytotoxin by the suicide gene product, resulting in
destruction of the rapidly dividing neointimal cells.
